CYTOSORBENTS CORP (CTSO) Stock Balance Sheet
NASDAQ:CTSO • US23283X2062
Current stock price
0.6049 USD
-0.02 (-2.45%)
Last:
| 2025 (2025-12-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 6.25M | 3.28M | 14.13M | 22.14M | 52.14M | |||
| Receivables | 7.55M | 7.32M | 6.06M | 5.66M | 4.52M | |||
| Inventories | 5.28M | 2.73M | 3.38M | 3.46M | 4.77M | |||
| Other Current Assets | 1.55M | 8.27M | 1.83M | 2.49M | 2.87M | |||
| Total Current Assets | 20.63M | 21.60M | 25.40M | 33.76M | 64.30M | |||
| Non-Current Assets | ||||||||
| PPE Net | 18.75M | 20.51M | 22.12M | 23.35M | 18.57M | |||
| Intangibles | 3.23M | 3.75M | 3.91M | 4.39M | 4.70M | |||
| Other Non-Current Assets | 1.57M | 1.51M | 1.54M | 1.73M | 1.94M | |||
| Total Non-Current Assets | 23.55M | 25.77M | 27.56M | 29.47M | 25.22M | |||
| TOTAL ASSETS | 44.18M | 47.37M | 52.96M | 63.23M | 89.52M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | N/A | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | N/A | 0.00 | 2.50M | N/A | N/A | |||
| Accrued Expenses | 6.84M | 5.47M | 4.78M | 4.68M | 6.47M | |||
| Accounts Payable | 2.87M | 3.34M | 3.80M | 1.66M | 2.81M | |||
| Other Current Liabilities | N/A | 1.02M | 2.96M | 3.38M | 4.41M | |||
| Total Current Liabilities | 9.71M | 9.82M | 14.04M | 9.71M | 13.69M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 16.67M | 14.00M | 2.54M | 5.00M | 0.00 | |||
| Other Non-Current Liabilities | 11.90M | 12.44M | 12.90M | 13.14M | 13.25M | |||
| Total Non-Current Liabilities | 28.57M | 26.44M | 15.44M | 18.15M | 13.25M | |||
| TOTAL LIABILITIES | 38.28M | 36.26M | 29.48M | 27.86M | 26.94M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -312.21M | -304.01M | -283.29M | -254.00M | -221.19M | |||
| Additional Paid In Capital | 321.02M | 310.81M | 306.19M | 287.00M | 283.19M | |||
| Common Shares | 63.00K | 54.80K | 54.20K | 40.00K | 40.00K | |||
| Other Shareholders' Equity | -2.98M | 4.25M | 529.30K | 2.33M | 530.00K | |||
| Shares Outstanding | 62.80M | 54.83M | 54.24M | 43.64M | 43.48M | |||
| Tangible Book Value per Share | 0.04 | 0.13 | 0.36 | 0.71 | 1.33 | |||
| Total Shareholders' Equity | 5.90M | 11.11M | 23.48M | 35.37M | 62.58M | |||
| TOTAL LIABILITIES AND EQUITY | 44.18M | 47.37M | 52.96M | 63.23M | 89.52M | |||
| Statistics | ||||||||
| Debt/Equity | 2.82 | 1.26 | 0.11 | 0.14 | N/A | |||
| Current Ratio | 2.13 | 2.20 | 1.81 | 3.48 | 4.70 | |||
| Return On Assets (ROA) | -18.56% | -43.74% | -55.23% | -51.89% | -27.44% | |||
| Return On Equity (ROE) | -138.88% | -186.54% | -124.55% | -92.76% | -39.25% | |||
All data in USD , ROIC based on taxRate of 0.21